Randomized Trial of Clinical Safety of Daily Oral Tenofovir Disoproxil Fumarate Among HIV-Uninfected Men Who Have Sex With Men in the United States

2013178 citationsJournal Article

Authors

Daily oral TDF was well tolerated, with reasonable adherence. No significant renal concerns were identified.

Good health and well-being

Published in: JAIDS Journal of Acquired Immune Deficiency Syndromes

Volume 64, Issue 1, pp. 79-86

Field-Weighted Citation Impact: 8.83